EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 27 (2020) Parasite, 27 (2020) 59 Full HTML
Open Access
Issue
Parasite
Volume 27, 2020
Article Number 59
Number of page(s) 4
DOI https://doi.org/10.1051/parasite/2020057
Published online 16 November 2020

© A.G. Mihu et al., published by EDP Sciences, 2020

Licence Creative CommonsThis is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Introduction

Toxoplasma gondii is a single-celled, obligate intracellular protozoan parasite. Contact with this parasite causes the infection called toxoplasmosis. In humans, the infection is transmitted either by ingestion of food or water contaminated with oocysts or by eating undercooked or raw meat that contains tissue cysts [13]. Usually, in immunocompetent individuals, toxoplasmosis remains asymptomatic and undiagnosed. If T. gondii primary infection occurs during pregnancy, this parasite may cause congenital infection with devastating consequences to the infected child, including chorioretinitis, blindness, cerebral calcifications, hydrocephalus, microcephaly, or developmental delay. Due to the severe complications of congenital toxoplasmosis, the seroprevalence of T. gondii in women of childbearing age should be monitored [2, 16, 18].

Seroprevalence of T. gondii IgG antibodies in women of childbearing age varies between countries and sometimes between regions within a country, ranging from 4% in South Korea to 84% in Madagascar [6]. A higher rate of latent toxoplasmosis has been associated with low-income, developing countries [23]. Developing countries in Africa report a high prevalence. In Ethiopia, for example, seroprevalence of T. gondii IgG antibodies in women of childbearing age is as high as 78.4% [8], and in Cameroon the seroprevalence of these antibodies is 54% [26]. In highly industrialised countries such as the United States, seroprevalence of T. gondii IgG antibodies is around 9% [10].

The overall seroprevalence of T. gondii IgG antibodies in Europe, in women of childbearing age, was estimated at 23% in 2014 [6]. Seroprevalence varies in different countries: 37% in France [14], 25.9% in Germany [27], 33% in Serbia [22], and 29.1% in Croatia [25].

In Romania, there is a lack of knowledge on the current epidemiological situation regarding toxoplasmosis, because only small-scale studies have been performed until now. In addition, no national screening programme for pregnant women and congenital toxoplasmosis have been implemented. Previous reports have shown that T. gondii infection is endemic in Western Romania [15, 17]. However, no studies regarding T. gondii seroprevalence have been conducted among women of childbearing age in Arad County, Western Romania. Therefore, we decided to assess the seroprevalence of T. gondii infection in women of childbearing age from this region.

Materials and methods

We investigated serum samples collected from 2626 women of childbearing age. The women were 15–45 years of age and were residents of Arad County, which has a population of 409,072 inhabitants. Samples were collected from 01 January 2016 to 31 December 2018, and no clinical criteria were used to include individuals in this study.

Women were grouped into six categories based on their age when the sample was drawn: 15–19 years, 20–24 years, 25–29 years, 30–34 years, 35–39 years, and 40–45 years.

Serum samples were screened for IgG anti-T. gondii antibodies using ADVIA Centaur ® XP (Siemens Healthcare Diagnostics, USA), according to the manufacturer’s instructions and internal laboratory standards. This test detects IgG antibodies using a chemiluminescence method. A value above 10 IU/mL was considered positive, inconclusive values ranged between 6.4 and 10 IU/mL, and values below 6.4 IU/mL were negative. For the purposes of this study, inconclusive values were considered negative.

Data were collected using Microsoft Excel, version 2011 (Microsoft Corp., Redmond, WA, USA), and statistical analyses were performed with the Epi Info statistical package 3.3.2 (Centers for Disease Control and Prevention, Atlanta, GA, USA). Mantel–Haenszel chi-square and two-tailed Fisher’s exact tests were used for comparison between groups. A p-value of <0.05 was considered statistically significant.

This study was approved by the Victor Babes University Ethics Committee, Timisoara, Romania.

Results

Toxoplasma gondii IgG antibodies were found in 1081 of 2626 females (41.16%), and the prevalence tended to increase with age. A statistically significant higher seroprevalence was observed in women 40–45 years old (61.53%) when compared to those 15–19 years (32.14%) (p = 0.03). No statistically significant difference in seroprevalence was found when we compared women 15–19 years (32.14%) with those 20–24 years (38.92%) (p = 0.28), 24–29 years (42.79%) (p = 0.18), 30–34 years (39.57%) (p = 0.27), and 35–39 years (39.42%) (p = 0.28) (Table 1). When data were analysed according to the area of residence (urban or rural) a higher seroprevalence of IgG antibodies was found in women from rural areas (46.06%, 614/1333) when compared to women from urban areas (36.11%, 467/1293) (p = 0.001) (Table 1).

Table 1

Seroprevalence of Toxoplasma gondii infection in women of childbearing age according to age and area of residence.

The T. gondii IgG antibodies seroprevalence tended to increase with age in both rural and urban areas.

Discussion

This study demonstrated the presence of T. gondii IgG antibodies in serum samples of 41.16% of women of childbearing age living in Arad county, a well-known endemic area of Romania. The seroprevalence was higher than that reported by other European investigators: 24.1% in Northern Kosovo and Metohija [22], 22.3% in Italy [5], 22% in Portugal [7], and 29.1% in Croatia [25]. The differences in seroprevalence of T. gondii IgG antibodies between countries can be explained by different nutritional habits, as well as sociodemographic and cultural factors [17, 19]. However, seroprevalence of T. gondii infection in our study was lower than the 57.6% reported in women of childbearing age from Timis county, Romania, one of the neighbouring counties [15]. Toxoplasma gondii seroprevalence may vary within a country and sometimes between different communities in one region [17, 20]. We have no explanation for this difference because participants were not interviewed regarding additional risk factors such as meat consumption, contact with cats or soil, occupation, economic status, or education level. It is possible that some of these potential exposure factors could contribute to the difference in T. gondii seroprevalence between Arad and Timis counties.

In the current study, the seroprevalence was higher in women from rural areas (46.06%) compared to those from urban areas (36.11%). Similar findings were reported by Olariu et al. and Vilibic-Cavlek et al. [15, 25]. This can be explained by the activities carried out in rural areas which may expose individuals to contaminated water or soil [24]. Farming, gardening, and handling animals are factors that may contribute to a higher prevalence in women residing in rural areas [12]. Prevalence rates are influenced by geographic differences and may be explained by exposure to the main sources of infection: tissue cysts acquired from undercooked meat, or oocysts found in soil contaminated by cat faeces. Feral cats that defecate in gardens or sandboxes may pose a risk of T. gondii infection in some people, regardless of whether they own a cat [1, 3, 9, 11].

As previously reported by other authors, seroprevalence of T. gondii infection in our study showed an age-related increase, with lower rates found in younger women. This type of association probably occurred due to longer exposure to the risk factors associated with T. gondii infection [19, 21].

No epidemiological investigations or questionnaires were conducted in this study. However, a seroprevalence of 70% of T. gondii antibodies was previously reported in cats in Western Romania, which may contribute to the high seroprevalence in our studied group [4].

The present study brings new epidemiological information on the prevalence of T. gondii infection in women of childbearing age from Arad County, Western Romania. Our results indicate a high prevalence of T. gondii infection in this study group. Further studies should be conducted to determine the main risk factors that contribute to such seroprevalence. This knowledge is vital to predict and prevent the risk of infection in pregnant women in the future. The serological status of women of childbearing age provides valuable information on immunity, which may help to prevent congenital infection by identifying women at risk. Our findings may serve as a starting point for counselling and education programmes on toxoplasmosis in antenatal clinics, and for the implementation at the national level of a screening and prevention programme for pregnant women.

Declaration of interest

The authors report that they have no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

References

  1. Belluco S, Patuzzi I, Ricci A. 2018. Bovine meat versus pork in Toxoplasma gondii transmission in Italy: a quantitative risk assessment model. International Journal of Food Microbiology, 269, 1–11. [CrossRef] [PubMed] [Google Scholar]
  2. Codaccioni C, Picone O, Lambert V, Maurice P, Pomar L, Winer N, Guibaud L, Lavergne RA, Saliou AH, Quinio D, Benachi A, Noel C, Ville Y, Cuillier F, Pomares C, Ferret N, Filisetti D, Weingertner AS, Vequeau-Goua V, Cateau E, Benoist G, Wallon M, Dommergues M, Villena I, Mandelbrot L. 2020. Ultrasound features of fetal toxoplasmosis: A contemporary multicenter survey in 88 fetuses. Prenatal Diagnosis, 2, Online ahead of print. https://doi.org/10.1002/pd.5756. [Google Scholar]
  3. Dabritz HA, Conrad PA. 2010. Cats and Toxoplasma: implications for public health. Zoonoses Public Health, 57(1), 34–52. [Google Scholar]
  4. Darabus G, Hotea I, Oprescu I, Morariu S, Brudiu I, Olariu RT. 2011. Toxoplasmosis seroprevalence in cats and sheep from Western Romania. Revue de Médecine Vétérinaire, 162, 316. [Google Scholar]
  5. Fanigliulo D, Marchi S, Montomoli E, Trombetta CM. 2020. Toxoplasma gondii in women of childbearing age and during pregnancy: seroprevalence study in Central and Southern Italy from 2013 to 2017. Parasite, 27, 2. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  6. Flegr J, Prandota J, Sovičková M, Israili ZH. 2014. Toxoplasmosis–a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS One, 9(3), e90203. [CrossRef] [PubMed] [Google Scholar]
  7. Gargaté MJ, Ferreira I, Vilares A, Sarvi S, Amouei A, Shokri A, Rahimi MT, Hosseini SA, Daryani A. 2016. Toxoplasma gondii seroprevalence in the Portuguese population: comparison of three cross-sectional studies spanning three decades. BMJ Open, 2016(6), e011648. [Google Scholar]
  8. Gebremedhin EZ, Abebe AH, Tessema TS, Tullu KD, Medhin G, Vitale M, Di Marco V, Cox E, Dorny P. 2013. Seroepidemiology of Toxoplasma gondii infection in women of child-bearing age in central Ethiopia. BMC Infectious Diseases, 13, 101. [CrossRef] [PubMed] [Google Scholar]
  9. Hussain MA, Stitt V, Szabo EA, Nelan B. 2017. Toxoplasma gondii in the Food Supply. Pathogens, 6(2), 21. [Google Scholar]
  10. Jones JL, Kruszon-Moran D, Rivera HN, Price C, Wilkins PP. 2014. Toxoplasma gondii seroprevalence in the United States 2009–2010 and comparison with the past two decades. American Journal of Tropical Medicine and Hygiene, 90(6), 1135–1139. [CrossRef] [Google Scholar]
  11. Lilly EL, Wortham CD. 2013. High prevalence of Toxoplasma gondii oocyst shedding in stray and pet cats (Felis catus) in Virqginia, United States. Parasites & Vectors, 6, 266. [CrossRef] [PubMed] [Google Scholar]
  12. Mizani A, Alipour A, Sharif M, Sarvi S, Amouei A, Shokri A, Rahimi MT, Hosseini SA, Daryani A. 2017. Toxoplasmosis seroprevalence in Iranian women and risk factors of the disease: a systematic review and meta-analysis. Tropical Medicine and Health, 45, 7. [CrossRef] [PubMed] [Google Scholar]
  13. Montoya JG, Liesenfeld O. 2004. Toxoplasmosis. Lancet, 363, 1965–1976. [CrossRef] [PubMed] [Google Scholar]
  14. Nogareda F, Le Strat Y, Villena I, De Valk H, Goulet V. 2014. Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980–2020: model-based estimation. Epidemiology and Infection, 142, 1661–1670. [CrossRef] [PubMed] [Google Scholar]
  15. Olariu TR, Darabus G, Cretu O, Jurovits O, Giura E, Erdelean V, Marincu I, Iacobiciu I, Petrescu C, Koreck A. 2008. Prevalence of Toxoplasma gondii antibodies among women of childbearing age in Timis County. Lucrări Stiintifice Medicină Veterinară Timisoara, 41, 367–371. [Google Scholar]
  16. Olariu TR, Remington JS, McLeod R, Alam A, Montoya JG. 2011. Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants. Pediatric Infectious Disease Journal, 30(12), 1056–1061. [CrossRef] [Google Scholar]
  17. Olariu TR, Petrescu C, Darabus G, Lighezan R, Mazilu O. 2015. Seroprevalence of Toxoplasma gondii in Western Romania. Infectious Diseases, 47(8), 580–583. [CrossRef] [PubMed] [Google Scholar]
  18. Olariu TR, Press C, Talucod J, Olson K, Montoya JG. 2019. Congenital toxoplasmosis in the United States: clinical and serologic findings in infants born to mothers treated during pregnancy. Parasite, 26, 13. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  19. Olariu TR, Ursoniu S, Hotea I, Dumitrascu V, Anastasiu D, Lupu MA. 2020. Seroprevalence and risk factors of Toxoplasma gondii infection in pregnant women from Western Romania. Vector Borne and Zoonotic Diseases, 20(10), 763–767. [CrossRef] [Google Scholar]
  20. Pappas G, Roussos N, Falagas ME. 2009. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. International Journal for Parasitology, 39(12), 1385–1394. [CrossRef] [PubMed] [Google Scholar]
  21. Peyron F, Wallon M, Kieffer F, Garweg J. 2016. Toxoplasmosis, in Infectious Diseases of the Fetus and Newborn Infant, 7th edn, Remington JS, Klein JO, Wilson CB, Nizet V, Maldonado Y, Editors. Elsevier Saunders: Philadelphia, PA. p. 949–1042. [Google Scholar]
  22. Pribakovic JA, Katanic N, Radevic T, Tasic MS, Kostic M, Stolic B, Radulovic A, Minic V, Bojovic K, Katanic R. 2019. Serological status of childbearing-aged women for Toxoplasma gondii and cytomegalovirus in northern Kosovo and Metohija. Revista da Sociedade Brasileira de Medicina Tropical, 52, e20170313. [CrossRef] [PubMed] [Google Scholar]
  23. Rostami A, Riahi SM, Gamble HR, Fakhri Y, Nourollahpour Shiadeh M, Danesh M, Behniafar H, Paktinat S, Foroutan M, Mokdad AH, Hotez PJ, Gasser RB. 2020. Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysis. Clinical Microbiology and Infection, 26(6), 673–683. [CrossRef] [Google Scholar]
  24. Shapiro K, Bahia-Oliveira L, Dixon B, Dumètre A, de Wit LA, VanWormer E, Villena I. 2019. Environmental transmission of Toxoplasma gondii: oocysts in water, soil and food. Food and Waterborne Parasitology, 15, e00049. [CrossRef] [PubMed] [Google Scholar]
  25. Vilibic-Cavlek T, Ljubin-Sternak S, Ban M, Kolaric B, Sviben M, Mlinaric-Galinovic G. 2011. Seroprevalence of TORCH infections in women of childbearing age in Croatia. Journal of Maternal-Fetalal and Neonatal Medicine, 24(2), 280–283. [CrossRef] [Google Scholar]
  26. Wam EC, Sama LF, Ali IM, Ebile WA, Aghangu LA, Tume CB. 2016. Seroprevalence of Toxoplasma gondii IgG and IgM antibodies and associated risk factors in women of child-bearing age in Njinikom, NWCameroon. BMC Research Notes, 9, 406. [CrossRef] [PubMed] [Google Scholar]
  27. Wilking H, Thamm M, Stark K, Aebischer T, Seeber F. 2016. Prevalence, incidence estimations and risk factors of Toxoplasma gondii infection in Germany: a representative, cross-sectional, serological study. Scientific Reports, 6, 22551. [CrossRef] [PubMed] [Google Scholar]

Cite this article as: Mihu AG, Balta C, Marti DT, Paduraru AA, Lupu MA & Olariu TR. 2020. Seroprevalence of Toxoplasma gondii infection among women of childbearing age in an endemic region of Romania, 2016–2018. Parasite 27, 59.

All Tables

Table 1

Seroprevalence of Toxoplasma gondii infection in women of childbearing age according to age and area of residence.

In the text

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.